Tag Archives: AERI

The CSO of Aerie Pharma is Exercising Options

Yesterday it was reported that the CSO of Aerie Pharma (AERI – Research Report), Casey Kopczynski, exercised options to buy 117,000 AERI shares at $0.40 a share, for a total transaction value of $46.8K. The options were close to expired

Monday’s Midday Stock Update: Karyopharm Therapeutics (KPTI), Peabody Energy Comm (BTU), Arrowhead Research (ARWR), Blueprint Medicines (BPMC), Aerie Pharma (AERI)

So far Monday, December 2, NASDAQ is down -4.72% and the S&P is down -2.6%. Here are this morning’s most active stocks: Karyopharm Therapeutics (KPTI – Research Report), Peabody Energy Comm (BTU – Research Report), Arrowhead Research (ARWR – Research

Needham Keeps Their Buy Rating on Aerie Pharma (AERI)

In a report released today, Serge Belanger from Needham maintained a Buy rating on Aerie Pharma (AERI – Research Report), with a price target of $40.00. The company’s shares closed last Monday at $19.09, close to its 52-week low of

Needham Keeps a Buy Rating on Aerie Pharma (AERI)

In a report released today, Serge Belanger from Needham maintained a Buy rating on Aerie Pharma (AERI – Research Report), with a price target of $40.00. The company’s shares closed last Monday at $19.13, close to its 52-week low of

Friday’s Midday Movers: Ebix (EBIX), Teva Pharmaceutical Industries (TEVA), Aerie Pharma (AERI)

So far Friday, November 15, NASDAQ is up 0.09% and the S&P is up 0.34%. Here are this morning’s most active stocks: Ebix (EBIX – Research Report), Teva Pharmaceutical Industries (TEVA – Research Report) and Aerie Pharma (AERI – Research

Mizuho Securities Reiterates a Buy Rating on Aerie Pharma (AERI)

In a report released today, Difei Yang from Mizuho Securities reiterated a Buy rating on Aerie Pharma (AERI – Research Report), with a price target of $54.00. The company’s shares closed last Monday at $23.82. According to TipRanks.com, Yang has